	Treatment-free interval as a determinant of second-line chemotherapy outcomes in extensive-stage small cell lung cancer: a Dutch population-based study. Lung Cancer Eijkelboom AH, Peters BJM, Dumoulin DW, Schramel FMNH, Damhuis RAM, van Geffen WH. PMID: 42721617 [PubMed - as supplied by publisher]
	Association between daily step counts and frailty trajectory classes in lung cancer patients undergoing radiotherapy: a prospective longitudinal study. J Cancer Surviv Zhang J, Wu J, Li S, Wu X, Ran L, Zhao X. PMID: 42720908 [PubMed - as supplied by publisher]
	Improved quality of life and prolonged survival with add-on homeopathic treatment in patients with non-small cell lung cancer: a prospective, randomized, placebo-controlled, double-blind, three-arm, multicenter study. Support Care Cancer Frass M, Lechleitner P, Gründling C, Gaertner K, Duscheck C, Muchitsch I, Manchanda RK, Burghuber OC. PMID: 42720799 [PubMed - indexed for MEDLINE]
	Tumor microenvironment-mediated resistance to immune checkpoint inhibitors in non-small cell lung cancer: Mechanisms, combination strategies and clinical perspectives (Review). Mol Clin Oncol Mu J, Xu Q. PMID: 42719683 [PubMed]
	Surgical Interval as a Risk Factor for Postoperative Complications After Repeated Lung Cancer Resection: A Retrospective Cohort Study. Ann Thorac Surg Short Rep Kadomatsu Y, Nakanishi K, Ueno H, Kato T, Nakamura S, Mizuno T, Chen-Yoshikawa TF. PMID: 42719611 [PubMed]
	Underrepresentation of Patients From Racial and Ethnic Minorities in Immunotherapy Clinical Trials for Non-Small Cell Lung Cancer. Ann Thorac Surg Short Rep Srinivasan D, Mathey-Andrews C, Venkateswaran S, Sanchez A, Potter AL, Mansur A, Schumacher L, Jeffrey Yang CF. PMID: 42719169 [PubMed]
	Study Designs for INTerpath-002 and INTerpath-009 of Adjuvant Intismeran Autogene Plus Pembrolizumab for Non-Small Cell Lung Cancer. Ann Thorac Surg Short Rep Spicer JD, Peters S, Gainor JF, Chaft JE, Bestvina CM, Lee JM, Marron TU, Khattak MA, Ojalvo LS, Banerjee JK, Wang Z, Deng X, Shariati N, Keller SM, Cascone T. PMID: 42719123 [PubMed]
	Association between serum tumor necrosis factor-alpha levels and rheumatoid arthritis-associated interstitial lung disease: a cross-sectional study. Front Immunol Li X, Leng L, Han Y, Zhang J, Shang X, Zhang S, Liu D, Qiao Y. PMID: 42719018 [PubMed - indexed for MEDLINE]
	Exploratory task-specific evaluation of large language models in lung cancer clinical scenarios: A comparative study. Digit Health Zhang W, Li X, Yuan R, Zhang Y, Yang Y, Xu Y, Zhong R, Chen S, Liu D, Gao L, Hu K. PMID: 42719007 [PubMed]
	Risk-adapted use of thoracic radiotherapy in stage IV non-small cell lung cancer: a multicenter prognostic model study. Front Oncol Guo J, Ji G, Zhang J, Zhang T, Wei X, Lin Y, Zhao L. PMID: 42718716 [PubMed]
	NLRC4 and NLRP3 in tissues as potential biomarkers for the diagnosis of non-small cell lung cancer in pulmonary tuberculosis. Front Cell Infect Microbiol Zhang Z, Zhao Z, Xie S, Guo B, Cai C, Wu C, Hao X, Ni J, Cui H, Xiong M. PMID: 42718658 [PubMed - indexed for MEDLINE]
	Efficacy of traditional Chinese medicine nursing for lung cancer: a systematic review and meta-analysis using the Donabedian model to investigate heterogeneity. Front Public Health Duan T, Liu Y. PMID: 42718599 [PubMed - indexed for MEDLINE]
	Diagnostic value of peripheral blood leukocyte parameters, NE-WX, LY-Y, MO-WY, MO-Y, MO-Z, and NE-SFL, in lung cancer. Front Oncol Tian W, Yuan Y, Hu Y, Bai L, Gao L. PMID: 42718557 [PubMed]
	Anti-Lung Cancer Agent Discovery and Development: A Review of Cross-Platform Correlation Across in silico, Network Pharmacology, in vitro, and in vivo Assessments. Drug Des Devel Ther Megantara S, Rohani R, Zakaria MR, S Biu MT, Kamarulzaman EE, Rusdin A. PMID: 42718449 [PubMed - indexed for MEDLINE]
	Mobile cone-beam computed tomography combined with electromagnetic navigation bronchoscopy for the diagnosis of peripheral pulmonary nodules. Pulmonology Ye L, Hong S, Zheng X, Chen J, Xie F, Liu S, Xi H, Ge J, Cai X, Sun J. PMID: 42717748 [PubMed - indexed for MEDLINE]
	Comparison of in-field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity-modulated proton therapy in lung cancer patients. J Appl Clin Med Phys Xu Y, Chen W, Wu J, Guo H, Zeng F, Zhang T, Yang F, Huang X, Zhang D, Wang X. PMID: 42717736 [PubMed - indexed for MEDLINE]
	Depression as a Risk of Lung Cancer in Women: a Nationwide Cohort Study. Tuberc Respir Dis (Seoul) Chung C, Lee KN, Han K, Shin DW, Lee SW. PMID: 42717670 [PubMed - as supplied by publisher]
	Improved Locoregional Recurrence-Free Survival With Carbon Ion Versus Photon Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer. Cancer Med Liu Y, Ma N, Li Y, Mi J, Fan X, Chen J, Mao J, Jiang G, Wu K. PMID: 42717470 [PubMed - indexed for MEDLINE]
	Advancements in Immunotherapy for Lung Cancer: A Meta-Analysis of Clinical Trial Outcomes. Clin Respir J Jiao Y, Zhao Y. PMID: 42716675 [PubMed - indexed for MEDLINE]
	A 40-Year-Old Woman With Exertional Dyspnea and Unexplained Hypoxia. Chest Liang YD, Meng WQ, Wang YX, Gu T, Zhong XF, Qiao LS, Xu XM. PMID: 42716631 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 161922

Page 1 of 8097



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy